Back to comparisons

Comparison

Huperzine A vs Acetyl-L-Carnitine (ALCAR)

FieldHuperzine AAcetyl-L-Carnitine (ALCAR)
Categorycholinergiccholinergic
Dose range0.05–0.2mg500–2000mg
Half-life12h4h
Onset60min60min
EvidenceEVIDENCEAEVIDENCEB
Safety●●●○○●●●●●
Legal (US)USOTCUSOTC
PubMed refs380600

The comparison in plain English

Auto-generated from data

Huperzine A and Acetyl-L-Carnitine (ALCAR) are both in the cholinergic category respectively. Huperzine A Potent acetylcholinesterase inhibitor derived from Chinese club moss. Acetyl-L-Carnitine (ALCAR) Acetylated form of L-carnitine that crosses the BBB.

Bottom line

Huperzine A (evidence A, safety 3/5) has a weaker evidence base than Acetyl-L-Carnitine (ALCAR) (evidence B, safety 5/5). Acetyl-L-Carnitine (ALCAR) has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Huperzine A if

Huperzine A is the better fit when your goal aligns with its mechanism (Reversibly inhibits acetylcholinesterase, preventing the breakdown of acetylcholine in synaptic clefts and prolonging cholinergic signalling) and the dose range (0.05–0.2mg) suits your protocol. Half-life is 12h.

Choose Acetyl-L-Carnitine (ALCAR) if

Acetyl-L-Carnitine (ALCAR) is the better fit when your goal aligns with its mechanism (Donates an acetyl group that can be used in acetylcholine synthesis — a direct cholinergic input distinct from phospholipid choline sources) and the dose range (500–2000mg) suits your protocol. Half-life is 4h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →